BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31617158)

  • 1. Proteomic profiling of peritoneal dialysis effluent-derived extracellular vesicles: a longitudinal study.
    Carreras-Planella L; Soler-Majoral J; Rubio-Esteve C; Morón-Font M; Franquesa M; Bonal J; Troya-Saborido MI; Borràs FE
    J Nephrol; 2019 Dec; 32(6):1021-1031. PubMed ID: 31617158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and proteomic profile of extracellular vesicles from peritoneal dialysis efflux.
    Carreras-Planella L; Soler-Majoral J; Rubio-Esteve C; Lozano-Ramos SI; Franquesa M; Bonet J; Troya-Saborido MI; Borràs FE
    PLoS One; 2017; 12(5):e0176987. PubMed ID: 28489901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple extracellular vesicle types in peritoneal dialysis effluent are prominent and contain known biomarkers.
    Pearson LJ; Klaharn IY; Thongsawang B; Manuprasert W; Saejew T; Somparn P; Chuengsaman P; Kanjanabuch T; Pisitkun T
    PLoS One; 2017; 12(6):e0178601. PubMed ID: 28594924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoprotein 96 in Peritoneal Dialysis Effluent-Derived Extracellular Vesicles: A Tool for Evaluating Peritoneal Transport Properties and Inflammatory Status.
    Fang J; Tong Y; Ji O; Wei S; Chen Z; Song A; Li P; Zhang Y; Zhang H; Ruan H; Ding F; Liu Y
    Front Immunol; 2022; 13():824278. PubMed ID: 35222405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost-effective method to get insight into the peritoneal dialysate effluent proteome.
    Araújo JE; Jorge S; Teixeira E Costa F; Ramos A; Lodeiro C; Santos HM; Capelo JL
    J Proteomics; 2016 Aug; 145():207-213. PubMed ID: 27216641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial.
    Szeto CC; Chow KM; Lam CW; Leung CB; Kwan BC; Chung KY; Law MC; Li PK
    Nephrol Dial Transplant; 2007 Feb; 22(2):552-9. PubMed ID: 17005526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, proteomics study identified potential biomarkers of encapsulating peritoneal sclerosis in peritoneal effluent.
    Zavvos V; Buxton AT; Evans C; Lambie M; Davies SJ; Topley N; Wilkie M; Summers A; Brenchley P; Goumenos DS; Johnson TS
    Kidney Int; 2017 Oct; 92(4):988-1002. PubMed ID: 28673451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of ACE inhibitors and AII receptor blockers on peritoneal membrane transport characteristics in long-term peritoneal dialysis patients.
    Kolesnyk I; Dekker FW; Noordzij M; le Cessie S; Struijk DG; Krediet RT
    Perit Dial Int; 2007; 27(4):446-53. PubMed ID: 17602154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The plasma permeability factor in nephrotic syndrome: indirect evidence in pediatric peritoneal dialysis.
    Azocar M; Quiroz L; Delucchi A; Dinamarca H; Emilfork M; Cano F
    Perit Dial Int; 2012; 32(4):437-43. PubMed ID: 22473035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Large Intraperitoneal Residual Volume Hampers Adequate Volumetric Assessment of Osmotic Conductance to Glucose.
    Clause AL; Keddar M; Crott R; Darius T; Fillee C; Goffin E; Morelle J
    Perit Dial Int; 2018; 38(5):356-362. PubMed ID: 29674410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of combination therapy with peritoneal dialysis and hemodialysis on peritoneal function.
    Moriishi M; Kawanishi H; Tsuchiya S
    Adv Perit Dial; 2010; 26():67-70. PubMed ID: 21348383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of NGAL in Peritoneal Dialysis Effluent in Early Diagnosis of Peritonitis: Case-Control Study in Peritoneal Dialysis Patients.
    Martino F; Scalzotto E; Giavarina D; Rodighiero MP; Crepaldi C; Day S; Ronco C
    Perit Dial Int; 2015; 35(5):559-65. PubMed ID: 25395499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial Peptide Ligand Library and two dimensional electrophoresis: new frontiers in the study of peritoneal dialysis effluent in pediatric patients.
    Bruschi M; Candiano G; Santucci L; D'Ambrosio C; Scaloni A; Bonsano M; Ghiggeri GM; Verrina E
    J Proteomics; 2015 Feb; 116():68-80. PubMed ID: 25585130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis.
    Pecoits-Filho R; Carvalho MJ; Stenvinkel P; Lindholm B; Heimbürger O
    Perit Dial Int; 2006; 26(1):53-63. PubMed ID: 16538876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal Equilibration Test Reference Values Using a 3.86% Glucose Solution During the First Year of Peritoneal Dialysis: Results of a Multicenter Study of a Large Patient Population.
    La Milia V; Cabiddu G; Virga G; Vizzardi V; Giuliani A; Finato V; Feriani M; Filippini A; Neri L; Lisi L;
    Perit Dial Int; 2017; 37(6):633-638. PubMed ID: 28698252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
    Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
    Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic Characterization of Peritoneal Extracellular Vesicles in a Mouse Model of Peritoneal Fibrosis.
    Huang Q; Sun Y; Sun J; Peng L; Shang H; Wei D; Li C; Hu Z; Peng H
    J Proteome Res; 2023 Mar; 22(3):908-918. PubMed ID: 36648763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations Between Peritoneal Glucose Exposure, Glucose Degradation Product Exposure, and Peritoneal Membrane Transport Characteristics in Peritoneal Dialysis Patients: Secondary Analysis of the
    Nataatmadja MS; Johnson DW; Pascoe EM; Darssan D; Hawley CM; Cho Y;
    Perit Dial Int; 2018; 38(5):349-355. PubMed ID: 30087174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Change in Peritoneal Function in Patients on Continuous Ambulatory PD vs Automated PD.
    Samad N; Fan SL
    Perit Dial Int; 2017; 37(6):627-632. PubMed ID: 28970363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What are the problems with using the peritoneal membrane for long-term dialysis?
    Bargman JM; Krediet RT; Lo WK; Selgas R; del Peso G; Auxiliadora Bajo M; Mujais S
    Semin Dial; 2008; 21(1):11-23. PubMed ID: 18251949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.